Wolverine Trading, LLC Intra Cellular Therapies, Inc. Transaction History

Wolverine Trading, LLC

$103 Billion
Q4 2024

A detailed history of Wolverine Trading, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 4,700 shares of ITCI stock, worth $619,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,700

Previous 2,757 70.48%

Holding current value

$619,507

Previous $201,000 95.02%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $23,116 - $27,485	-340 Reduced 10.98%	2,757 $201,000
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $91,959 - $113,372	-1,420 Reduced 31.44%	3,097 $212,000
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $290,759 - $341,711	4,517 New	4,517 $312,000
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $376,767 - $490,227	8,602 New	8,602 $482,000
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $93,104 - $141,295	-2,645 Reduced 32.69%	5,445 $284,000
Q3 2021 Nov 12, 2021	SELL	$28.72 - $42.49 $16,255 - $24,049	-566 Reduced 6.54%	8,090 $290,000
Q3 2020 Nov 13, 2020	SELL	$17.61 - $31.86 $64,980 - $117,563	-3,690 Reduced 29.89%	8,656 $221,000
Q2 2020 Aug 13, 2020	SELL	$14.35 - $26.64 $65,852 - $122,250	-4,589 Reduced 27.1%	12,346 $311,000
Q4 2019 Feb 12, 2020	BUY	$7.26 - $38.49 $863 - $4,580	119 Added 0.71%	16,935 $570,000
Q2 2019 Aug 20, 2019	SELL	$10.65 - $14.29 $9,414 - $12,632	-884 Reduced 4.99%	16,816 $218,000
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $18,268 - $23,614	1,676 Added 10.46%	17,700 $216,000
Q4 2018 Feb 14, 2019	SELL	$10.36 - $20.96 $192,468 - $389,394	-18,578 Reduced 53.69%	16,024 $181,000
Q3 2018 Nov 14, 2018	BUY	$17.77 - $22.9 $412,850 - $532,035	23,233 Added 204.35%	34,602 $751,000
Q1 2018 May 15, 2018	BUY	$15.16 - $25.49 $15,993 - $26,891	1,055 Added 10.23%	11,369 $239,000
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $147,180 - $173,172	10,314	10,314 $149,000

Others Institutions Holding ITCI

# of Institutions

418

Shares Held

87.7M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.4B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Intra Cellular Therapies, Inc. Transaction History